Φορτώνει......
MERS-CoV spike nanoparticles protect mice from MERS-CoV infection
The Middle East respiratory syndrome coronavirus (MERS-CoV) was first discovered in late 2012 and has gone on to cause over 1800 infections and 650 deaths. There are currently no approved therapeutics or vaccinations for MERS-CoV. The MERS-CoV spike (S) protein is responsible for receptor binding an...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Vaccine |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Elsevier Ltd.
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5423355/ https://ncbi.nlm.nih.gov/pubmed/28237499 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2017.02.012 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|